Research Topics
| R T BurkmanSummaryAffiliation: Baystate Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Health economics of contraceptionR T Burkman
Department of Obstetrics and Gynecology, Tufts University School of Medicine, Boston, Massachusetts, USA
Obstet Gynecol Clin North Am 27:917-31, viii. 2000..To date, there has been limited application of these methods to the area of contraception...- The transdermal contraceptive systemRonald T Burkman
Department of Obstetrics Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
Am J Obstet Gynecol 190:S49-53. 2004..Side effects are similar to those seen with OCs with the exception of application site reactions that are obviously unique to transdermal delivery... - Current controversies: hormone replacement therapy and breast cancerRonald T Burkman
Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts 01199, USA
Obstet Gynecol Surv 58:633-5. 2003 - Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences StudyRonald T Burkman
National Cancer Institute Surveillance, Epidemiology, and End Results Registry, Department of Obstetrics and Gynecology, Henry Ford Health System, Detroit, Michigan, USA
Fertil Steril 79:844-51. 2003..To determine the association between infertility drug use and invasive breast cancer in a population-based case-control study... - Hormone replacement therapy. Current controversiesR T Burkman
Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA, USA
Minerva Ginecol 55:107-16. 2003..The risk of colorectal cancer is decreased with use of hormone replacement therapy. In addition, the risk of osteopenia and osteoporosis is decreased as is the risk of osteoporotic fracture... - Safety concerns and health benefits associated with oral contraceptionRonald Burkman
Department of Obstetrics Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
Am J Obstet Gynecol 190:S5-22. 2004..Some of these benefits include reduction in menstrual-related symptoms, fewer ectopic pregnancies, a possible increase in bone density, and possible protection against pelvic inflammatory disease... - Venous thromboembolism and oral contraceptives: current status and clinical implicationsRonald T Burkman
Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts 01199, USA
Treat Endocrinol 1:143-7. 2002.... - Reproductive hormones and cancer: ovarian and colon cancerRonald T Burkman
Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
Obstet Gynecol Clin North Am 29:527-40. 2002..Available data are limited. Finally, there is growing evidence that hormone replacement therapy reduces risk of colorectal cancer, a benefit that accrues to perimenopausal women... 
Association between efficacy and body weight or body mass index for two low-dose oral contraceptivesRonald T Burkman
Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
Contraception 79:424-7. 2009..This analysis investigated the association of oral contraceptive efficacy with body weight and body mass index (BMI) for hypothesis-generating purposes...- Transdermal hormonal contraception: benefits and risksRonald T Burkman
Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
Am J Obstet Gynecol 197:134.e1-6. 2007..Despite this, the contraceptive patch may be an appropriate option for some patients... - Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of useRonald T Burkman
Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, MA 01199, USA
J Reprod Med 52:1030-4. 2007..To compare the effect of 2 oral contraceptives (OCs) on body weight... - The transdermal contraceptive patch: a new approach to hormonal contraceptionRonald T Burkman
Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts, USA
Int J Fertil Womens Med 47:69-76. 2002..Partial or total detachment of the patch occurs at an overall rate of 3.8%. This rate is not affected by warm humid climates, vigorous exercise, or exposure to saunas or water baths... - Hormone replacement therapy regimens and breast cancer risk(1)Linda K Weiss
Population Studies and Prevention Program, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA
Obstet Gynecol 100:1148-58. 2002..Progestin administered in an uninterrupted regimen may be a contributing factor. Risk dissipates once use is discontinued... - Do thyroid disorders increase the risk of breast cancer?Michael S Simon
Division of Hematology and Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, Michigan, USA
Cancer Epidemiol Biomarkers Prev 11:1574-8. 2002..There was no statistical interaction between thyroid disorders, thyroid treatments, and race, menopausal status, or parity. We found no association between thyroid disorders or their associated treatments and the risk of breast cancer... - Racial differences in the familial aggregation of breast cancer and other female cancersMichael S Simon
Division of Haematology and Oncology, Barbara Ann Karmanos Cancer Institute, 4100 John R, 4221 Hudson, Weber Cancer Research Building, Detroit, M1 48201, USA
Breast Cancer Res Treat 89:227-35. 2005..17 (1.22-3.85). In conclusion, these racially distinct aggregation patterns may reflect different modes of inheritance and/or environmental factors that impact cancer risk... - Breast cancer risk estimates for relatives of white and African American women with breast cancer in the Women's Contraceptive and Reproductive Experiences StudyMichael S Simon
Division of Hematology and Oncology, Karmanos Cancer Institute at Wayne State University, Detroit, MI 48201, USA
J Clin Oncol 24:2498-504. 2006..The purpose of this report is to update breast cancer risk estimates associated with a family history of breast cancer for white and AA women... - Current perspectives on benefits and risks of hormone replacement therapyR T Burkman
Department of Obstetrics and Gynecology, Tufts University School of Medicine, Boston, MA USA
Am J Obstet Gynecol 185:S13-23. 2001..Overall, estrogen and hormone replacement therapy improves the quality of life and increases life expectancy for most menopausal women... - Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trialAndrew M Kaunitz
Department of Obstetrics and Gynecology, University of Florida College of Medicine, Jacksonville, Florida, USA
Obstet Gynecol 114:1205-12. 2009..To compare bleeding patterns between a 21/7-day triphasic norgestimate/ethinyl estradiol (E2) 25-microgram oral contraceptive pill (OCP) and a 24/4-day drospirenone/ethinyl E2 20-microgram OCP... - Clinical pearls: factors affecting reported contraceptive efficacy rates in clinical studiesRonald T Burkman
Department of Obstetrics and Gynecology, Baystate Medical Center, Springfield, Massachusetts 01199, USA
Int J Fertil Womens Med 47:153-61. 2002..Furthermore, clinical trial data may not accurately predict contraceptive efficacy in everyday use... - Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral densityChristine C Johnson
Henry Ford Hospital, Detroit, MI 48202 3450, USA
Contraception 77:239-48. 2008..nonuse of the injectable (intramuscular) contraceptive depot medroxyprogesterone acetate (DMPA-IM) and its effect on bone mass in adolescent women... - Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancerBrian L Strom
Center for Clinical Epidemiology and Biostatistics and Department of Biostatistics and Epidemiology, 824 Blockley Hall, 423 Guardian Drive, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
Contraception 69:353-60. 2004..This study does not support an increased risk of breast cancer associated with the use of injectable or implantable progestin-only contraceptives in women aged 35 to 64... - Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences StudyJulia A Knight
Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 60 Murray Street, Box 18, Toronto, ON, Canada, M5T 3L9
Breast Cancer Res Treat 109:157-64. 2008..Additional studies are required to determine the specific cyst type(s) responsible for the observed relationship... - Risk of breast cancer associated with short-term use of oral contraceptivesSuzanne G Folger
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Cancer Causes Control 18:189-98. 2007..To estimate breast cancer risk associated with short-term (<6 months) oral contraceptive use, and explore variation in estimates by use characteristics and medical, menstrual, and reproductive history... - The transdermal contraceptive patch: an updated review of the literatureKatharine O'Connell
Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
Clin Obstet Gynecol 50:918-26. 2007..Although concern has been raised about a possible increased risk of venous thromboembolism, current available data comparing the patch to a norgestimate-containing OC ranges from no increase in risk to a 2.4-fold increase... - Reproductive hormones and cardiovascular disease mechanism of action and clinical implicationsJanice D Wagner
Department of Pathology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1040, USA
Obstet Gynecol Clin North Am 29:475-93. 2002..The remainder of the study groups including an estrogen-only arm, are expected to continue until 2005... - Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancerChristopher I Li
Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M4 C308, P O Box 19024, Seattle, WA 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 15:946-54. 2006.... - Lifetime recreational exercise activity and breast cancer risk among black women and white womenLeslie Bernstein
Department of Preventive Medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033, USA
J Natl Cancer Inst 97:1671-9. 2005.... - Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinomaJanet R Daling
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
Cancer 95:2455-64. 2002..However, the use of combined (estrogen and progestin) hormone replacement therapy (CHRT) also has increased during the last decade and may account in part for the increase in invasive lobular breast carcinoma... - Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 yearsJanet R Daling
Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Seattle, Washington 98109 1024, USA
Cancer Epidemiol Biomarkers Prev 12:1175-81. 2003.... - Oral contraceptives and the risk of breast cancerPolly A Marchbanks
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, USA
N Engl J Med 346:2025-32. 2002..CONCLUSIONS: Among women from 35 to 64 years of age, current or former oral-contraceptive use was not associated with a significantly increased risk of breast cancer... - The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational resultsPolly A Marchbanks
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Ann Epidemiol 12:213-21. 2002..5% and 78.6%, respectively, with lower rates for black women and older women. CONCLUSIONS: The methodologic details of this large collaboration may assist researchers conducting similar investigations... - Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal womenSandra A Norman
Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
Cancer Causes Control 14:933-43. 2003..We examined breast cancer risk related to lifetime exposure to oral contraceptives (OCs) and hormone replacement therapy (HRT) in postmenopausal women... - Timing of menarche and first full-term birth in relation to breast cancer riskChristopher I Li
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Am J Epidemiol 167:230-9. 2008..The authors conclude that the interval between age at menarche and age at first birth is associated with the risk of hormonally sensitive types of breast cancer, particularly among White women... - Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 yearsKathleen E Malone
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Cancer Res 66:8297-308. 2006.... - Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patchFrank A Sonnenberg
University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, NJ 08903, USA
Am J Obstet Gynecol 192:1-9. 2005..The purpose of this study was to examine implications of increased perfect use on the cost-effectiveness of the contraceptive patch compared with combination oral contraceptives (COCs)... - Alcohol exposure and breast cancer: results of the women's contraceptive and reproductive experiences studyJill A McDonald
National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health, 4770 Buford Highway Northeast, MS-K22, Atlanta, GA 30341-3724, USA
Cancer Epidemiol Biomarkers Prev 13:2106-16. 2004..Further work is needed to explain how alcohol exposure, sex hormones, and tumor receptor status interact... - Reproductive factors and risk of breast carcinoma in a study of white and African-American womenGiske Ursin
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90089, USA
Cancer 101:353-62. 2004.... - Costs and net health effects of contraceptive methodsFrank A Sonnenberg
Division of General Internal Medicine, UMDNJ Robert Wood Johnson Medical School, 125 Paterson Street, Room 2302, New Brunswick, NJ 08903 USA
Contraception 69:447-59. 2004..Pregnancy and contraceptive methods both have important health effects that include risks and benefits. The net impact of contraception on women's health has not been reported previously...